ARTICLE | Company News
FDA approves CSL's Idelvion
March 5, 2016 1:23 AM UTC
FDA approved Idelvion albutrepenonacog alfa ( CSL654) from CSL Ltd. (ASX:CSL) to prevent or control bleeding in adults or children with hemophilia B. ...
FDA approved Idelvion albutrepenonacog alfa ( CSL654) from CSL Ltd. (ASX:CSL) to prevent or control bleeding in adults or children with hemophilia B. ...